THERAVITARX Trademark

Trademark Overview

On Sunday, August 31, 2025, a trademark application was filed for THERAVITARX with the United States Patent and Trademark Office. The USPTO has given the THERAVITARX trademark a serial number of 99367418. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, April 30, 2026. The THERAVITARX trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infective products for veterinary use; antiparasitic preparations; anti-dermoinfectives
theravitarx

General Information

Serial Number99367418
Word MarkTHERAVITARX
Filing DateSunday, August 31, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, April 30, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2026

Trademark Statements

Goods and ServicesAnti-infective products for veterinary use; antiparasitic preparations; anti-dermoinfectives
Pseudo MarkTHERA VITA RX; THERAVITA RX

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, August 31, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressVALLEY STREAM, NY 11580
US

Trademark Events

Event DateEvent Description
Sunday, August 31, 2025NEW APPLICATION ENTERED
Sunday, August 31, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, August 31, 2025APPLICATION FILING RECEIPT MAILED
Thursday, January 15, 2026ASSIGNED TO EXAMINER
Wednesday, January 21, 2026NON-FINAL ACTION WRITTEN
Wednesday, January 21, 2026NON-FINAL ACTION E-MAILED
Wednesday, January 21, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 27, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 27, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 29, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 19, 2026SUSPENSION LETTER WRITTEN
Thursday, February 19, 2026LETTER OF SUSPENSION E-MAILED
Thursday, February 19, 2026NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sunday, March 8, 2026TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, March 13, 2026ASSIGNED TO LIE
Friday, March 13, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 13, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 15, 2026NON-FINAL ACTION WRITTEN
Wednesday, April 15, 2026NON-FINAL ACTION E-MAILED
Wednesday, April 15, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 22, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 22, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 22, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 23, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 13, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Related Keywords

theravitarx anti preparations dermoinfectives antiparasitic veterinary infective products